...granted Tap a license to develop and distribute ilaprazole worldwide, excluding South Korea and China. Il-Yang... ...Phase II trials in 2006 to treat erosive esophagitis and non-erosive gastroesophageal reflux disease (GERD). Il-Yang...
AXP received an option to exclusively license Il Yang's IY-81149 antiulcerant proton-pump inhibitor, which is in Phase II testing, outside China and Korea. Il Yang, in turn, received an option to exclusively license in China...
...granted Tap a license to develop and distribute ilaprazole worldwide, excluding South Korea and China. Il-Yang... ...Phase II trials in 2006 to treat erosive esophagitis and non-erosive gastroesophageal reflux disease (GERD). Il-Yang...
AXP received an option to exclusively license Il Yang's IY-81149 antiulcerant proton-pump inhibitor, which is in Phase II testing, outside China and Korea. Il Yang, in turn, received an option to exclusively license in China...
